Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer.
Kubeczko M, Gabryś D, Gawkowska M, Polakiewicz-Gilowska A, Cortez AJ, Krzywon A, Woźniak G, Latusek T, Leśniak A, Świderska K, Mianowska-Malec M, Łanoszka B, Chomik K, Gajek M, Michalik A, Nowicka E, Tarnawski R, Rutkowski T, Jarząb M. Kubeczko M, et al. Among authors: jarzab m. Cancers (Basel). 2023 Jan 22;15(3):690. doi: 10.3390/cancers15030690. Cancers (Basel). 2023. PMID: 36765648 Free PMC article.
Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
Kubeczko M, Jarząb M, Gabryś D, Krzywon A, Cortez AJ, Xu AJ. Kubeczko M, et al. Among authors: jarzab m. Radiother Oncol. 2024 May;194:110188. doi: 10.1016/j.radonc.2024.110188. Epub 2024 Mar 6. Radiother Oncol. 2024. PMID: 38447357 Free article. No abstract available.
Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
Jarzab M, Kowal M, Bal W, Oczko-Wojciechowska M, Rembak-Szynkiewicz J, Kowalska M, Stobiecka E, Chmielik E, Tyszkiewicz T, Kaszuba M, Nowicka E, Lange B, Czarniecka A, Krajewska J, Dyla A, Dobrut M, Lange D, Jarzab B, Bobek-Billewicz B, Tarnawski R. Jarzab M, et al. Among authors: jarzab b. Folia Histochem Cytobiol. 2016;54(4):202-209. doi: 10.5603/FHC.a2016.0026. Epub 2017 Jan 4. Folia Histochem Cytobiol. 2016. PMID: 28051275 Free article.
Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
Duchnowska R, Jarząb M, Żebracka-Gala J, Matkowski R, Kowalczyk A, Radecka B, Kowalska M, Pfeifer A, Foszczyńska-Kłoda M, Musolino A, Czartoryska-Arłukowicz B, Litwiniuk M, Surus-Hyla A, Szabłowska-Siwik S, Karczmarek-Borowska B, Dębska-Szmich S, Głodek-Sutek B, Sosińska-Mielcarek K, Chmielowska E, Kalinka-Warzocha E, Olszewski WP, Patera J, Żawrocki A, Pliszka A, Tyszkiewicz T, Rusinek D, Oczko-Wojciechowska M, Jassem J, Biernat W; Polish Brain Metastasis Consortium. Duchnowska R, et al. Among authors: jarzab m. Clin Breast Cancer. 2017 Apr;17(2):e65-e75. doi: 10.1016/j.clbc.2016.08.008. Epub 2016 Sep 8. Clin Breast Cancer. 2017. PMID: 27692773
Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.
Oczko-Wojciechowska M, Swierniak M, Krajewska J, Kowalska M, Kowal M, Stokowy T, Wojtas B, Rusinek D, Pawlaczek A, Czarniecka A, Szpak-Ulczok S, Gawlik T, Chmielik E, Tyszkiewicz T, Nikiel B, Lange D, Jarzab M, Wiench M, Jarzab B. Oczko-Wojciechowska M, et al. Among authors: jarzab b, jarzab m. Sci Rep. 2017 Feb 9;7:42074. doi: 10.1038/srep42074. Sci Rep. 2017. PMID: 28181547 Free PMC article.
122 results